Posted in M&A / Deals Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data April 8, 2026 BioSpace Another bidder, which remains unidentified, dropped out of the bidding process. M&A / DealsHematologyRead full story